NAD Metabolism and Signaling Conference

NAD代谢和信号传导会议

基本信息

  • 批准号:
    7673197
  • 负责人:
  • 金额:
    $ 1.15万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-04-15 至 2010-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Over the last several years there has been a great resurgence in the interest of the vitamin B3-derived metabolite, nicotinamide adenine dinucleotide (NAD+), including the various pathways to its biosynthesis and the signaling molecules generated from its consumption. There was a sense in the late 20th century that NAD+ was entirely understood and was too abundant to be regulatory. Mainly, this conclusion stemmed from the well-known functions of NAD+, NADH, NADP and NADPH as co-enzymes for hydride transfer enzymes, such as oxidoreductases, which play central roles in intermediary metabolism. However, the numerous investigators assembled for this 2009 summer FASEB meeting have demonstrated that NAD+ is consumed in a wide variety of regulatory pathways, synthesized from unanticipated vitamins and intermediates, and is processed to novel regulatory metabolites with unanticipated activities. Since these new discoveries, more and more laboratories have realized the need to understand the complete metabolome of NAD+, e.g. NAD+ metabolites and related signaling molecules. Today, NAD+ investigators are drawn from all areas of biology, biological chemistry, cell biology, physiology and medicine. The assemblies of investigators who have agreed to participate in this meeting constitute the first FASEB meeting on NAD+ metabolism and signaling. This meeting is the first of its kind to offer a single venue that brings together NAD+-minded researchers from diverse areas of NAD+ controlled enzymatic processes. This meeting will provide fundamental background in multi-systems and multi-scale functions of NAD+, and provide interdisciplinary training in nutrition, enzymology, signaling, cell biology, physiology, diabetes, immunology/inflammation and aging. This conference should provide an excellent training opportunity for young scientists, who have an opportunity to present their work and learn the about the latest developments. Topic areas will include the cellular pathways and medical implications of such NAD+- dependent enzymes as sirtuins, glycohydrolases, oxidoreductases, PARPs, PARGs, and ADP-ribosyl cyclases, as well as NAD+ synthesizing enzymes and NAD+ kinases. Programmatic discussions will emphasize integration of current knowledge to develop a systems biology view of the NAD+ metabolome.
描述(由申请人提供):在过去几年中,人们对维生素B3衍生代谢物烟酰胺腺嘌呤二核苷酸(NAD+)的兴趣再次高涨,包括其生物合成的各种途径和其消耗产生的信号分子。在世纪后期,人们有一种感觉,即NAD+已被完全理解,而且含量太高,无法进行监管。这一结论主要源于NAD+、NADH、NADP和NADPH作为氢化物转移酶(如氧化还原酶)的辅酶的众所周知的功能,所述氢化物转移酶在中间代谢中起核心作用。然而,为2009年夏季FASEB会议聚集的众多研究人员已经证明,NAD+在各种各样的调节途径中被消耗,从未预料到的维生素和中间体合成,并被加工成具有未预料到的活性的新型调节代谢物。自从这些新发现以来,越来越多的实验室已经意识到需要了解NAD+的完整代谢组,例如NAD+代谢物和相关信号分子。如今,NAD+研究人员来自生物学、生物化学、细胞生物学、生理学和医学的各个领域。同意参加本次会议的研究人员组成了关于NAD+代谢和信号传导的第一次FASEB会议。这次会议是第一次提供一个单一的场所,汇集了来自NAD+控制酶过程不同领域的NAD+思想研究人员。本次会议将提供NAD+多系统和多尺度功能的基础背景,并提供营养学,酶学,信号传导,细胞生物学,生理学,糖尿病,免疫学/炎症和衰老的跨学科培训。这次会议将为青年科学家提供一个极好的培训机会,他们有机会介绍他们的工作并了解最新的发展情况。主题领域将包括细胞途径和NAD+依赖酶如sirtuins,糖水解酶,氧化还原酶,PARP,PARG和ADP-核糖基环化酶,以及NAD+合成酶和NAD+激酶的医学意义。程序讨论将强调当前知识的整合,以开发NAD+代谢组的系统生物学观点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOHN M DENU其他文献

JOHN M DENU的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOHN M DENU', 18)}}的其他基金

Dynamics and molecular mechanisms linking metabolism and the epigenome
连接代谢和表观基因组的动力学和分子机制
  • 批准号:
    10624003
  • 财政年份:
    2023
  • 资助金额:
    $ 1.15万
  • 项目类别:
Dietary regulation of the hepatic epigenome
肝脏表观基因组的饮食调节
  • 批准号:
    10211950
  • 财政年份:
    2021
  • 资助金额:
    $ 1.15万
  • 项目类别:
Dietary regulation of the hepatic epigenome
肝脏表观基因组的饮食调节
  • 批准号:
    10434846
  • 财政年份:
    2021
  • 资助金额:
    $ 1.15万
  • 项目类别:
Dietary regulation of the hepatic epigenome
肝脏表观基因组的饮食调节
  • 批准号:
    10640272
  • 财政年份:
    2021
  • 资助金额:
    $ 1.15万
  • 项目类别:
Linking mitochondrial variation and lifespan amongst five species of Rodentia
将五种啮齿目动物的线粒体变异与寿命联系起来
  • 批准号:
    9077372
  • 财政年份:
    2016
  • 资助金额:
    $ 1.15万
  • 项目类别:
Role of Sirt3 in Aging and Caloric Restriction
Sirt3 在衰老和热量限制中的作用
  • 批准号:
    8706746
  • 财政年份:
    2011
  • 资助金额:
    $ 1.15万
  • 项目类别:
Role of Sirt3 in Aging and Caloric Restriction
Sirt3 在衰老和热量限制中的作用
  • 批准号:
    8313913
  • 财政年份:
    2011
  • 资助金额:
    $ 1.15万
  • 项目类别:
Role of Sirt3 in Aging and Caloric Restriction
Sirt3 在衰老和热量限制中的作用
  • 批准号:
    8512636
  • 财政年份:
    2011
  • 资助金额:
    $ 1.15万
  • 项目类别:
Role of Sirt3 in Aging and Caloric Restriction
Sirt3 在衰老和热量限制中的作用
  • 批准号:
    8025259
  • 财政年份:
    2011
  • 资助金额:
    $ 1.15万
  • 项目类别:
Reversible Protein Acetylation and Chromatin Function
可逆蛋白质乙酰化和染色质功能
  • 批准号:
    8005210
  • 财政年份:
    2010
  • 资助金额:
    $ 1.15万
  • 项目类别:

相似海外基金

Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
  • 批准号:
    24K18114
  • 财政年份:
    2024
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
  • 批准号:
    498288
  • 财政年份:
    2024
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Operating Grants
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
  • 批准号:
    10089306
  • 财政年份:
    2024
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Collaborative R&D
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
  • 批准号:
    498310
  • 财政年份:
    2024
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Operating Grants
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
  • 批准号:
    23K20339
  • 财政年份:
    2024
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
  • 批准号:
    2740736
  • 财政年份:
    2024
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Studentship
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
  • 批准号:
    2305890
  • 财政年份:
    2024
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Fellowship Award
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
  • 批准号:
    2406592
  • 财政年份:
    2024
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Standard Grant
McGill-MOBILHUB: Mobilization Hub for Knowledge, Education, and Artificial Intelligence/Deep Learning on Brain Health and Cognitive Impairment in Aging.
McGill-MOBILHUB:脑健康和衰老认知障碍的知识、教育和人工智能/深度学习动员中心。
  • 批准号:
    498278
  • 财政年份:
    2024
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Operating Grants
Welfare Enhancing Fiscal and Monetary Policies for Aging Societies
促进老龄化社会福利的财政和货币政策
  • 批准号:
    24K04938
  • 财政年份:
    2024
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了